This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research program) totaling $311,040 aims to investigate cancer screening rates and barriers among transgender and gender diverse (TGD) individuals in the United States. The project, awarded to Mayo Clinic, has two primary objectives: Analyzing a large insurance claims database to determine the actual rates of cancer screening mammography among...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides funding to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop and test a remote, digital behavioral intervention called "QuitVaping" to promote nicotine vaping cessation and prevent the escalation of tobacco use among youth. The $1,698,536 award, with a project period from September 6,...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $707,367 in funding to Kaiser Foundation Hospitals to evaluate a novel mobile health (mHealth) intervention for people who are ambivalent about quitting smoking. The key products and services to be delivered include: The development and evaluation of a smartphone app called GEMS that blends evidence-based smoking cessation treatments with theory-based content to engage,...
The University of Oklahoma Health Sciences Center was awarded a $100,000 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant, titled "Developing an Empowerment Theory-Based Smoking Cessation Intervention for Sexual and/or Gender Minority People with Community Partners," is focused on developing and pilot testing a smoking cessation intervention tailored for sexual and/or gender...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), provides $226,504.00 to George Washington University to conduct research on tobacco use behaviors and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The key objectives are to: 1) examine differences in tobacco use trajectories and polyproduct use among adults with specific minority identities...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will fund a mixed-methods study to explore strategies for enhancing alcohol treatment engagement and participation among transgender and gender diverse (TGD) adults. The $121,027 award, effective from September 14, 2024 to March 18, 2025, aims to: 1) identify factors that may increase the appeal and participation of alcohol...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $316,873 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to adapt a validated Spanish-language smoking cessation intervention into a smartphone app and conduct a pilot randomized controlled trial (RCT). The goals are to (1) develop a smartphone app version of the "Libre del Cigarrillo" intervention that has been...
This Project Grant award, with a total funding amount of $279,102.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The award will be used to refine and evaluate the effectiveness and implementation of a primary prevention intervention called "Gender-Affirming School Practices (GASP)," which is designed to promote healthy emotional and behavioral development in transgender adolescents. The key products...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $957,600.00 to Drexel University to develop a framework for community-directed tobacco harm reduction research. The key objectives are to: Investigate multilevel influences of empowerment strategies in mitigating tobacco use harms among Black and Latinx adult sexual and gender minority (SGM) populations in Philadelphia. This includes using...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $832,598 to the University of California, Santa Barbara to design a gender-affirming training intervention for lay health workers to promote mental health care access for racially diverse transgender youth. The key objectives are to: (1) co-design the training intervention with community partners including transgender youth, their parents, and...
This Project Grant award of $1,319,898 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will support the adaptation and pilot testing of a smoking cessation intervention for transgender and gender-diverse (TGD) individuals. The project aims to explore how gender minority stressors and associated anxiety/depression impact smoking cessation for TGD individuals, and adapt an existing cessation intervention to address their unique needs. The work will be led by researchers at The General Hospital Corporation (Massachusetts General Hospital) and will involve sub-awards to Boston University and Fenway Community Health Center to conduct focus groups, intervention adaptation, and a pilot randomized controlled trial. The pilot study will assess the feasibility and acceptability of the adapted intervention and evaluate its impact on 7-day point prevalence abstinence, cigarette use, gender minority stress, and mental health symptoms. If successful, the adapted intervention will advance to a larger hybrid efficacy/effectiveness trial.